Difficulty: Medium
Average Score: 64%
Practice
A 44-year-old man with multiple medical problems is placed on a carbonic anhydrase inhibitor which inhibits bicarbonate reabsorption and acts as a weak diuretic. This agent works at which of the following areas in the nephron?
Correct answer
A
Rationale
The correct answer is A) Location 1, which refers to the proximal convoluted tubule of the nephron. Carbonic anhydrase inhibitors like acetazolamide work by inhibiting the enzyme carbonic anhydrase in the proximal convoluted tubule. This inhibition leads to decreased reabsorption of bicarbonate, resulting in a mild diuretic effect.
Option B) Location 2, which is the loop of Henle, is incorrect because carbonic anhydrase inhibitors do not primarily act in this part of the nephron.
Option C) Location 3, which is the distal convoluted tubule, is also incorrect as carbonic anhydrase inhibitors do not target this specific area for their mechanism of action.
Option D) Location 4, which would be the collecting duct, is also an incorrect choice as carbonic anhydrase inhibitors primarily act in the proximal convoluted tubule.
Understanding the specific location of action of pharmacological treatments on the nephron is crucial for healthcare professionals to predict the drug's effects on renal physiology and overall patient care. This knowledge aids in selecting appropriate medications, monitoring for potential side effects, and optimizing therapeutic outcomes for clients across the lifespan.
Option B) Location 2, which is the loop of Henle, is incorrect because carbonic anhydrase inhibitors do not primarily act in this part of the nephron.
Option C) Location 3, which is the distal convoluted tubule, is also incorrect as carbonic anhydrase inhibitors do not target this specific area for their mechanism of action.
Option D) Location 4, which would be the collecting duct, is also an incorrect choice as carbonic anhydrase inhibitors primarily act in the proximal convoluted tubule.
Understanding the specific location of action of pharmacological treatments on the nephron is crucial for healthcare professionals to predict the drug's effects on renal physiology and overall patient care. This knowledge aids in selecting appropriate medications, monitoring for potential side effects, and optimizing therapeutic outcomes for clients across the lifespan.